Black Rock Inc. Allogene Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 16,445,682 shares of ALLO stock, worth $35.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,445,682

Previous 9,652,930 70.37%

Holding current value

$35.7 Million

Previous $43.1 Million 11.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.23 - $4.38 $15.1 Million - $29.8 Million	6,792,752 Added 70.37%	16,445,682 $38.3 Million
Q1 2024 May 10, 2024	SELL	$2.92 - $5.63 $1.02 Million - $1.96 Million	-348,874 Reduced 3.49%	9,652,930 $43.1 Million
Q4 2023 Feb 13, 2024	BUY	$2.28 - $3.5 $2.53 Million - $3.88 Million	1,107,824 Added 12.46%	10,001,804 $32.1 Million
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $1.42 Million - $2.67 Million	447,930 Added 5.3%	8,893,980 $28.2 Million
Q2 2023 Aug 11, 2023	SELL	$4.53 - $6.74 $3.07 Million - $4.56 Million	-677,042 Reduced 7.42%	8,446,050 $42 Million
Q1 2023 May 12, 2023	BUY	$4.92 - $8.21 $1.16 Million - $1.94 Million	236,520 Added 2.66%	9,123,092 $45.1 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $3.79 Million - $7.49 Million	673,992 Added 8.21%	8,886,572 $55.9 Million
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $2.14 Million - $3.58 Million	207,414 Added 2.59%	8,212,580 $88.7 Million
Q2 2022 Aug 12, 2022	BUY	$6.78 - $12.28 $6.23 Million - $11.3 Million	918,933 Added 12.97%	8,005,166 $91.3 Million
Q1 2022 May 12, 2022	BUY	$7.65 - $15.29 $4.29 Million - $8.57 Million	560,279 Added 8.59%	7,086,233 $64.6 Million
Q4 2021 Feb 10, 2022	SELL	$13.13 - $24.52 $9.78 Million - $18.3 Million	-745,238 Reduced 10.25%	6,525,954 $97.4 Million
Q3 2021 Nov 09, 2021	BUY	$21.01 - $27.64 $5.24 Million - $6.89 Million	249,253 Added 3.55%	7,271,192 $187 Million
Q2 2021 Aug 11, 2021	BUY	$23.49 - $35.8 $165 Million - $251 Million	7,021,939 New	7,021,939 $183 Million

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $312M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account